FDA Investigator Raquel L Coleman
Raquel L Coleman has inspections in 1 countries as of 27 Oct 2023. Raquel L Coleman has collaborated with a combined 1587 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
30
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adriana N Jimenez Lopez,
Alan Escalona,
Alec M O'neal,
Alex T Goodman,
Allison C Hunter,
Allison M Scheck,
Andrew M Kupper,
Anna M Brannen,
Arie R Dyk,
Arturo De La Garza,
Bailey A Uetrecht,
Benjamin D Motsinger,
Benjamin P Stewart,
Brenda C Hamilton,
Brian J Ryan,
Brittany M Kershaw,
Bryan J Love,
Carlos Hruiz Nunez,
Catherine D Djordjevic,
Chris B Dedic, RS,
Christian L Witkovskie,
Christina L Bigham,
Craig P Seaborn,
Craig T Rybus,
Daisy E Ramos,
Daniel J Gorski,
Darren S Morgan,
David Castillo,
David P Moorhead,
Diane R Mcdaniel,
Donna F Campbell,
Edward R Kay,
Elizabeth Ll Edwards,
Elizabeth P Kinsella,
Evan M Kupper,
Felipe Rde Almeida,
Green,
Gretchen N Kilby,
Heather A Mccauley,
Holly J Rapier,
Holly J Wilson,
Howard A Webley,
James G Marsh,
Jason Channels,
Jason D Werne,
Jason R Vidaurrie,
Javonica F Penn,
Jennifer A Pruden,
Jennifer L Gustavus,
Jessica M Wooten,
John D Jaworski,
John E Russell,
John P Roetting, II,
Jonathan A Ferguson,
Karen M Cooper,
Kathryn Carroll,
Katie L Korchinski,
Keith J Mason,
Kimberly A Joseph,
Kirk W Gaston,
Klein,
Krista S Tuggle,
Krista T Ferry,
Lauren N Smith,
Lauren R Collins,
Liliya V Bubiy,
Lindsey M Schwierjohann,
Luckner Jean Marie,
Maney P Sturgil,
Maney P Sturgill,
Marianne Allen,
Maribeth G Niesen,
Mary B Sheets,
Matt D Suedkamp,
Michael D Thatcher,
Michael E Barta,
Philip S Woodward,
Pifer,
Richard W Berning,
Robbie J Alleman,
Robert P Neligan,
Roy C Stephens,
State Agency,
Susan M Taylor,
Takiyah S Gilmore Embery,
Talmane J Fisher,
Thomas B Smith,
Thomas J Prigge,
Thomas W Nojek,
Tracey L Harris,
Troy A Huffman
Raquel L Coleman's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2023 | FDA 483 | J.M. Smucker LLC - Form 483, 2023-07-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more